Karthick Vasudevan

Dr. Karthick Vasudevan


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
AIAshok Iyaswamy
Ashok Iyaswamy
KLKejia Lu
Kejia Lu
XGXin-Jie Guan
Xin-Jie Guan
YKYuxuan Kan
Yuxuan Kan
CSCHENGFU SU
CHENGFU SU
MLMin LI
Min LI
Bacterial Extracellular Vesicles (BEVs) possess the capability of intracellular interactions with other cells, and, hence, can be utilized as an efficient cargo for worldwide delivery of therapeutic substances such as monoclonal antibodies, proteins, plasmids, siRNA, and small molecules for the treatment of neurodegenerative diseases (NDs). BEVs additionally possess a remarkable capacity for delivering these therapeutics across the blood–brain barrier to treat Alzheimer’s disease (AD). This review summarizes the role and advancement of BEVs for NDs, AD, and their treatment. Additionally, it investigates the critical BEV networks in the microbiome–gut–brain axis, their defensive and offensive roles in NDs, and their interaction with NDs. Furthermore, the part of BEVs in the neuroimmune system and their interference with ND, as well as the risk factors made by BEVs in the autophagy–lysosomal pathway and their potential outcomes on ND, are all discussed. To conclude, this review aims to gain a better understanding of the credentials of BEVs in NDs and possibly discover new therapeutic strategies.

12 April 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
APAthiram Pandaram
Athiram Pandaram
JPJeyakumari Paul
Jeyakumari Paul
WWWankupar Wankhar
Wankupar Wankhar
ATAbhimanyu Thakur
Abhimanyu Thakur
SVSakshi Verma
Sakshi Verma
RRRavindran Rajan
Ravindran Rajan
Aspartame, a widely used artificial sweetener, is present in many food products and beverages worldwide. It has been linked to potential neurotoxicity and developmental defects. However, its teratogenic effect on embryonic development and the underlying potential mechanisms need to be elucidated. We investigated the concentration- and time-dependent effects of aspartame on zebrafish development and teratogenicity. We focused on the role of sirtuin 1 (SIRT1) and Forkhead-box transcription factor (FOXO), two proteins that play key roles in neurodevelopment. It was found that aspartame exposure reduced the formation of larvae and the development of cartilage in zebrafish. It also delayed post-fertilization development by altering the head length and locomotor behavior of zebrafish. RNA-sequencing-based DEG analysis showed that SIRT1 and FOXO3a are involved in neurodevelopment. In silico and in vitro analyses showed that aspartame could target and reduce the expression of SIRT1 and FOXO3a proteins in neuron cells. Additionally, aspartame triggered the reduction of autophagy flux by inhibiting the nuclear translocation of SIRT1 in neuronal cells. The findings suggest that aspartame can cause developmental defects and teratogenicity in zebrafish embryos and reduce autophagy by impairing the SIRT1/FOXO3a axis in neuron cells.

4 April 2023 in Frontiers in Medicine
Verified
Journal Article
Open access
HDHrituraj Dey
Hrituraj Dey
KVKarthick Vasudevan
Karthick Vasudevan
GCGeorge Priya Doss C.
George Priya Doss C.
Udhaya Kumar. SUdhaya Kumar. S
Udhaya Kumar. S
AAAchraf El Allali
Achraf El Allali
HZHatem Zayed
Hatem Zayed
Introduction: Osteosarcoma is a rare disorder among cancer, but the most frequently occurring among sarcomas in children and adolescents. It has been reported to possess the relapsing capability as well as accompanying collateral adverse effects which hinder the development process of an effective treatment plan. Using networks of omics data to identify cancer biomarkers could revolutionize the field in understanding the cancer. Cancer biomarkers and the molecular mechanisms behind it can both be understood by studying the biological networks underpinning the etiology of the disease.Methods: In our study, we aimed to highlight the hub genes involved in gene-gene interaction network to understand their interaction and how they affect the various biological processes and signaling pathways involved in Osteosarcoma. Gene interaction network provides a comprehensive overview of functional gene analysis by providing insight into how genes cooperatively interact to elicit a response. Because gene interaction networks serve as a nexus to many biological problems, their employment of it to identify the hub genes that can serve as potential biomarkers remain widely unexplored. A dynamic framework provides a clear understanding of biological complexity and a pathway from the gene level to interaction networks.Results: Our study revealed various hub genes viz. TP53, CCND1, CDK4, STAT3, and VEGFA by analyzing various topological parameters of the network, such as highest number of interactions, average shortest path length, high cluster density, etc. Their involvement in key signaling pathways, such as the FOXM1 transcription factor network, FAK-mediated signaling events, and the ATM pathway, makes them significant candidates for studying the disease. The study also highlighted significant enrichment in GO terms (Biological Processes, Molecular Function, and Cellular Processes), such as cell cycle signal transduction, cell communication, kinase binding, transcription factor activity, nucleoplasm, PML body, nuclear body, etc.Conclusion: To develop better therapeutics, a specific approach toward the disease targeting the hub genes involved in various signaling pathways must have opted to unravel the complexity of the disease. Our study has highlighted the candidate hub genes viz. TP53, CCND1 CDK4, STAT3, VEGFA. Their involvement in the major signaling pathways of Osteosarcoma makes them potential candidates to be targeted for drug development. The highly enriched signaling pathways include FOXM1 transcription pathway, ATM signal-ling pathway, FAK mediated signaling events, Arf6 signaling events, mTOR signaling pathway, and Integrin family cell surface interactions. Targeting the hub genes and their associated functional partners which we have reported in our studies may be efficacious in developing novel therapeutic targets.

1 December 2021 in Current Opinion in Pharmacology
Verified
Journal Article
Closed access
KVKarthick Vasudevan
Karthick Vasudevan
TKThirumal Kumar
Thirumal Kumar
Udhaya Kumar. SUdhaya Kumar. S
Udhaya Kumar. S
ASAisha Saleem
Aisha Saleem
NNN. Nagasundaram
N. Nagasundaram
HZHatem Zayed
Hatem Zayed

27 June 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
AIAshok Iyaswamy
Ashok Iyaswamy
KLKejia Lu
Kejia Lu
XGXinjie Guan
Xinjie Guan
KYKan Yuxuan
Kan Yuxuan
CSCHENGFU SU
CHENGFU SU
MLMin LI
Min LI
Bacterial Extracellular Vesicles (BEVs) generated from the bacteria has high feasibility of intracellular interactions with other cells, can be used as a cargo to deliver any therapeutic substances like monoclonal antibodies, proteins, plasmids, siRNA and small molecules for the treatment of neurodegenerative diseases (NDs). BEVs have a high ability for delivering therapeutic molecules across the blood-brain barrier to treat Alzheimer's Disease (AD) via various mechanisms. In this review, we have sum up in-depth research details of the role and advancement of BEVs in NDs, AD and its Therapeutics. Moreover, details about offensive and defensive functions of BEVs in ND pathogenesis and examine the critical BEV networks in the microbiome-gut-brain axis and their role in neurodegenerative disorders. Additionally determining the roles of BEVs in the neuroimmune system and their interaction with neurodegenerative disorders and exploring the risk factors of BEVs in the autophagy-lysosomal pathway and their possible effects on neurodegenerative disorders are summarised in detail. In conclusion, this review seeks to contribute to a better understanding of the potential function of BEVs in NDs and to identify new therapeutic intervention strategies.

12 May 2025 in Infection
Verified
Journal Article
Closed access
PDF file
SVShruthi Vasanthaiah
Shruthi Vasanthaiah
PTPritibala Takey
Pritibala Takey
PSPrasanna Kumar Selvam
Prasanna Kumar Selvam
SMSupraja Mohan
Supraja Mohan
RKRavi Kiran
Ravi Kiran
KVKarthick Vasudevan
Karthick Vasudevan